Ampio clinical trial data is only a few weeks away. This is the only thing that matters. This biologic drug is going to be a game changer and AMPE price will be off the charts soon. The drug works as promised, patient registration for their clinical trials was fulfilled in lightning fast speeds. There are no open spots for other patients to enroll, that alone should tell you something. This is a FACT that no one can dispute. Worth a visit to clinicaltrials dot gov to see for yourself. The truth is what matters now and the truth can be found at legitimate sources like clinicaltrials dot gov and not some short bashing articles or the blogs of paid bashers like ampiooooh.
The shorts have fired their best shots at $AMPE and the stock is holding up nicely. They are about to learn their lesson soon, real soon. There's no turning back just full speed ahead. The attacks were all predicted and they all came. Shorts are running out of ammo, they've thrown their best at Ampio and they have all failed.
P3 for Ampion. All the information you're looking for is at ClinicalTrials dot gov. Search for NCT01839331.
Estimated Enrollment: 320
Study Start Date: March 2013
Estimated Study Completion Date: October 2013
Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)